TickerFacts.

Company research / ALXO

ALX ONCOLOGY HOLDINGS INC (ALXO)

Build a valuation ↗↓ Download CSV

CIK 0001810182 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2022-12-31, ALX ONCOLOGY HOLDINGS INC reported revenue of $0.

Key ratios (year ended 2022-12-31)

-46.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-18

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue———$0$0$1.18M$4.80M$2.07M—
Operating Income-$104.02M-$142.47M-$170.28M-$127.44M-$83.56M-$43.66M-$19.18M-$13.68M—
Net Income-$101.69M-$134.85M-$160.81M-$123.48M-$83.46M-$45.74M-$19.24M-$13.73M—
EPS (Diluted)$-1.90$-2.58$-3.74$-3.03$-2.07$-2.76———
Total Assets$59.05M$147.78M$242.55M$306.49M$380.18M$436.05M$10.68M——
Total Liabilities$33.06M$34.16M$52.84M$43.02M$17.13M$6.21M$10.95M——
Shareholders' Equity$25.98M$113.62M$189.71M$263.46M$363.05M$429.85M-$70.64M-$51.78M-$38.41M
Cash & Equivalents$16.37M$17.57M$22.41M$48.82M$363.67M$434.22M$9.02M——
Operating Cash Flow-$84.14M-$121.91M-$130.36M-$89.22M-$68.10M-$38.29M-$14.25M-$13.19M—
Capital Expenditures$212.0K$447.0K$1.27M$1.43M$666.0K$31.0K$353.0K$653.0K—
Shares Outstanding54.39M53.05M49.95M40.86M40.59M39.84M3.17M——
Weighted Average Diluted Shares53.66M52.17M42.99M40.70M40.31M18.49M———
EPS (Basic)$-1.90$-2.58$-3.74$-3.03$-2.07$-2.76———